Clinical Questions in Cardiology: Using Glucagon-like Peptide-1 Receptor Agonists

To participate in this activity, please:

Log in Sign Up

This activity is also available as a podcast: You may listen here

The glucagon-like peptide-1 receptor agonist (GLP-1RA) class of medications has become an important option for treating patients with type 2 diabetes mellitus (T2D). Cardiovascular outcome trials also show that selected GLP-1RAs exert beneficial cardiovascular benefits in patients with and without T2D. In this activity, case studies commonly encountered in cardiology practice are utilized to prompt reflection on opportunities for reducing cardiovascular risk. Drawing on seminal research and their own experience, cardiologist Jorge Plutzy, MD, and endocrinologist Helena Rodbard, MD, navigate through a series of ‘clinical questions’ to inform regarding the clinical pharmacology of the GLP-1RAs and their evidence-based role in cardiovascular risk reduction, particularly in patients with secondary atherosclerotic cardiovascular disease. The faculty also provide recommendations to optimize the use of GLP-1RAs as a class, as well as individually, including strategies to mitigate gastrointestinal adverse events and address patient concerns. In closing, Dr. Plutzky underscores the essential role of cardiologists in diabetes care, advocating for a collaborative, interprofessional team approach to optimize the health of patients with chronic coronary disease.

Course Credit:

1.25 AAPA Category I CME Credits
1.25 AMA PRA Category 1 CreditsTM
1.25 ANCC Contact Hours
1.25 CA-BRN Contact Hours
1.00 Pharmacology Hour

Dates:

Opens: 2024-01-31
Closes: 2025-02-28

Target Audience:

The target audience includes cardiologists and cardiology advanced practice providers who treat patients with type 2 diabetes (T2D), and other clinicians with an interest in T2D.

This activity is supported by an independent educational grant from Novo Nordisk.

Accreditation Information

    Presenting Faculty

  • Jorge Plutzky, MD

    Director, Preventive Cardiology
    Cardiovascular Medicine
    Brigham and Women's Hospital
    Boston, Massachusetts

  • Helena W. Rodbard, MD

    Past President, American Association of Clinical Endocrinologists (AACE)
    Past President, American College of Endocrinology (ACE)
    Founder and Medical Director, Endocrine and Metabolic Consultants
    Rockville, Maryland